US8835561023
US8835561023
Thermo Fisher Scientific Inc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 243.3B EUR | 185.38B EUR | 182.66B EUR | 218B EUR |
Enterprise Value | 279.68B EUR | 223.86B EUR | 222.57B EUR | 247.53B EUR |
Valuation Multiples | ||||
Trailing P/E | 35.42x | 26.61x | 26.67x | 41.95x |
Forward P/E | 23.86x | -- | -- | -- |
Price to Sales | 5.25x | 4x | 4.04x | 6.38x |
Price to Book | 4.62x | 3.52x | 3.52x | 4.08x |
EV/Revenue | 6.04x | 4.83x | 4.92x | 7.24x |
EV/EBITDA | 23.83x | 18.11x | 18.54x | 27.12x |
Price to FCF (P/FCF) | 39.01x | 25.33x | 27.07x | 36.75x |
EV/FCF | 44.84x | 30.59x | 32.98x | 41.73x |
FCF Yield | 2.56% | 3.95% | 3.69% | 2.72% |